Skip to content

Boric Acid

An intravaginal antiseptic with a genuine place in the treatment of recurrent vulvovaginal candidiasis, particularly infections caused by non-albicans species such as Candida glabrata that are intrinsically less susceptible to azole drugs.

  • CategoryHormonal & Wellness
  • Form600 mg intravaginal suppository (gelatin capsule)
  • EvidenceClinical trials on file

Where to get Boric Acid

iHerb
600 mg intravaginal suppository (gelatin capsule)

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesBoric acid is a weak Lewis acid, not a Bronsted acid, and that distinction is the start of its antifungal chemistry. In water it does not donate a proton; it accepts a hydroxide ion to form tetrahydroxyborate.
  • Who it is forWomen with culture-confirmed recurrent or non-albicans vulvovaginal candidiasis, working with a clinician. Nobody else.
  • What to watchNever swallow it. Oral boric acid is toxic and ingestion has caused death; the capsules look like any other capsule and must be stored where a child cannot reach them.

How Boric Acid works

Boric acid is a weak Lewis acid rather than a Bronsted acid — it accepts a hydroxide ion from water rather than donating a proton — and it forms reversible complexes with cis-diol groups on sugars and glycoproteins. Against Candida it appears to act at several points at once rather than on one enzyme: it inhibits the yeast-to-hypha transition, disrupts biofilm formation, and interferes with oxidative metabolism and membrane function.

Read the rest of how it works

That multiplicity is the mechanistic reason azole resistance does not confer cross-resistance to it, and it is why the species that matter clinically — Candida glabrata above all, whose fluconazole susceptibility is unreliable — remain susceptible. Applied intravaginally, systemic absorption across intact mucosa is limited; across ulcerated or inflamed mucosa it is not, which is why broken epithelium is a contraindication rather than a caution.

Boric Acid: serving, timing and spacing

Suggested serving
The dose in the literature is 600 mg intravaginally once daily for 14 days. It is not a maintenance product and it is not a daily hygiene product.
How often
Once daily for 14 days, intravaginally - a course, not a habit
When
At night, lying down, which is simply what keeps it where it was put. Finish the full 14 days: partial improvement at day four is usual and stopping there is the standard route from a treatable infection to a recurrent one
Spacing that matters for safety
Never orally, and never on broken or ulcerated mucosa. Store it away from oral supplements - it is a capsule that looks like every other capsule and swallowing it is a poisoning rather than a mistake

General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.

Good to know

A culture that names the species is what makes this a treatment rather than a guess. Used on symptoms alone it treats bacterial vaginosis, trichomoniasis and dermatitis as if they were yeast, and delays the diagnosis that would have worked.

Research on Boric Acid5 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • Expert consensus on topical treatment of recurrent vulvovaginal candidiasis includes intravaginal boric acid at 600 mg daily as an option for azole-refractory and non-albicans disease.

  • European expert panel opinion and narrative review of recurrent vulvovaginal candidosis management describes the same role and the same constraint — that the diagnosis should be confirmed by culture and speciation before it is used.

  • Reviews of vulvovaginal candidiasis guidelines place boric acid among the alternatives specifically for Candida glabrata, where fluconazole susceptibility is unreliable.

Correlative data

  • Recurrent vulvovaginal candidiasis affects a substantial minority of women and is a diagnosis routinely made without a culture, which is the reason a boric acid course so often fails: the majority of self-diagnosed yeast infections are something else.

Theoretical / extrapolated benefits

  • Boric acid appears to act as a fungistatic that interferes with Candida hyphal transition and biofilm formation rather than by a single enzyme target, which would explain why the azole resistance mechanisms do not confer cross-resistance to it.

Sources read for this page

  • Phillips NA. Topical Treatment of Recurrent Vulvovaginal Candidiasis: An Expert Consensus. Womens Health Rep (New Rochelle) 2022 · PMID 35136875
  • Neal CM. Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis. SAGE Open Med 2022 · PMID 36105548
  • Donders G. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion. Front Cell Infect Microbiol 2022 · PMID 36159646
  • Satora M. Treatment of Vulvovaginal Candidiasis: An Overview of Guidelines and the Latest Treatment Methods. J Clin Med 2023 · PMID 37629418
  • Willems HME. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J Fungi (Basel) 2020 · PMID 32106438
  • Rautemaa-Richardson R. State-of-the-Art Review: Managing Vulvovaginal Candidiasis. Clin Infect Dis 2026 · PMID 41839452

Boric Acid, the deep readThe mechanism, cell to human, which form, how you would know

What Boric Acid actually does

Boric acid is a weak Lewis acid, not a Bronsted acid, and that distinction is the start of its antifungal chemistry. In water it does not donate a proton; it accepts a hydroxide ion to form tetrahydroxyborate. The resulting boron center forms reversible covalent complexes with cis-diol groups — the arrangement found in ribose, in cell-wall polysaccharides, and in glycoproteins.

Against Candida it does not appear to have a single target, and that is the clinically useful part. The described effects are inhibition of the yeast-to-hypha transition, disruption of biofilm formation and architecture, interference with oxidative metabolism, and membrane and cell-wall disturbance Willems 2020. Hyphal transition is what turns a commensal yeast into a tissue-invading form, and biofilm is what makes recurrent infection recurrent, so both are the right targets rather than incidental ones.

The multiplicity explains the resistance pattern, which is the whole reason this molecule is still in guidelines. Azole resistance in Candida runs through ERG11 point mutations and through efflux-pump upregulation, both of which are specific to the azole target and the azole molecule. Neither confers cross-resistance to a boron compound acting at several points at once. That is why Candida glabrata — intrinsically less susceptible to fluconazole and responsible for a substantial share of non-albicans disease — remains susceptible Satora 2023 Rautemaa-Richardson 2026.

Absorption is the safety half of the mechanism. Across intact vaginal epithelium systemic absorption of boron is limited; across ulcerated or severely inflamed mucosa it is not, because the barrier that limits it is gone. That is why broken epithelium is a contraindication rather than a caution, and it is the same reason the oral route is dangerous — the gut absorbs boron essentially completely.

Cell, rodent, human — and where it stops

This page's chain is short because the molecule went into clinical use long before anybody characterized it, and the evidence sits in guidance documents rather than in mechanism papers.

In expert consensus. Topical treatment guidance for recurrent vulvovaginal candidiasis includes intravaginal boric acid at 600 mg daily as an option for azole-refractory and non-albicans disease Phillips 2022. A European expert panel review reaches the same position and attaches the same condition — that the diagnosis should be confirmed by culture and speciation before it is used Donders 2022.

In guideline reviews. Overviews of vulvovaginal candidiasis guidelines place boric acid among the alternatives specifically for C. glabrata Satora 2023, and a 2026 state-of-the-art review restates the role Rautemaa-Richardson 2026.

The specific obstacle to transfer is diagnostic rather than pharmacological, and it is the reason most courses fail. The clinical literature on recurrent vulvovaginal candidiasis is explicit that the condition is routinely diagnosed without a culture, and that a large share of self-diagnosed yeast infections are bacterial vaginosis, trichomoniasis, aerobic vaginitis, contact dermatitis or vulvodynia Neal 2022 Willems 2020. A drug that works on Candida glabrata does nothing for any of those, and using it delays the diagnosis that would have worked.

So the honest statement is that the evidence supports a well-defined use in a population defined by a laboratory result, and says nothing at all about the much larger population that buys it.

Boric Acid — which form, and does it matter

The form is the dose and the route together, and neither is negotiable. The studied product is 600 mg of boric acid powder in a gelatin capsule, inserted intravaginally once daily for 14 days Phillips 2022. Not a rinse, not a wash, not a daily maintenance capsule, and not an oral tablet.

What else is in the shell matters more than usual. Some products are boric acid alone; others add aloe or probiotic organisms. The evidence is for boric acid, and a combination product introduces a variable into a treatment being run against a laboratory diagnosis.

Rinses and douches sold under the same name are a different product. They deliver a different concentration for a different contact time and they have not been studied against the same endpoints. A search for this ingredient returns both, side by side, at similar prices.

Exposure arithmetic, and it is what makes the oral warning concrete. A 14-day course places 8.4 g of boric acid against the vaginal mucosa, where absorption across intact epithelium is limited. Swallowed, boron is absorbed nearly completely and cleared renally with a half-life on the order of a day, so the same capsule taken by the wrong route is a systemic dose. This is why the storage instruction — out of reach of children, out of the vitamin cupboard — is part of the product and not an afterthought.

What would have to be true, and how you would know it was not

There is no blood test for this one, and pretending otherwise would be inventing a read-out. The measurements are clinical and microbiological.

What to watch: symptom resolution — itch, discharge character, dyspareunia — scored before starting and at the end of the 14 days, and a repeat culture. The prediction the mechanism makes is specific: if the culture named C. glabrata or another non-albicans species, symptoms should improve over the course Donders 2022. If the culture named C. albicans and fluconazole had already failed, improvement is still expected but the resistance question belongs with the clinician.

How long before it means anything: the full 14 days. Partial improvement at day 4 is common and stopping there is the standard way to convert a treatable infection into a recurrent one.

What will fool you: the menstrual cycle. Vulvovaginal symptoms fluctuate with cyclical changes in vaginal pH and glycogen, so a course started at the symptomatic point of a cycle will appear to work as the cycle moves on. The second confound is the diagnosis itself: bacterial vaginosis remits and relapses spontaneously, and it is the condition most often mistaken for this one Neal 2022.

The prediction that cuts against use: if symptoms do not improve over 14 days, the most likely explanation is not resistance. It is that the diagnosis was wrong Willems 2020, and the correct next step is a swab rather than a second course.

What nobody has tested yet

Boric acid has been used intravaginally for over a century and has never had a large modern randomized trial. Its place in guidance rests on consensus, case series and small comparative work Phillips 2022 Rautemaa-Richardson 2026. That is a remarkable evidence gap for an intervention this widely recommended, and it is not the same thing as an absence of evidence for effect.

The effect on the vaginal microbiome is largely uncharacterized. Lactobacillus dominance is what keeps vaginal pH low and is protective against both candidiasis and bacterial vaginosis Willems 2020. Whether a 14-day boric acid course suppresses lactobacilli alongside the yeast — and therefore whether it predisposes to the next infection — has not been measured with modern sequencing.

And maintenance dosing is used without evidence. Some clinicians extend boric acid to twice-weekly maintenance after induction, by analogy with fluconazole maintenance Donders 2022. The analogy is reasonable and the trial has not been done, so the duration of safe use is genuinely unknown.

Boric Acid — its own safety story, not its category's

Never swallow it. Oral boric acid is toxic and ingestion has caused death. This is the first line of the safety section because the product is a capsule that looks like every other capsule, and because the route is the entire difference between a treatment and a poisoning. Store it away from oral supplements and out of reach of children.

Contraindicated in pregnancy. Boron is a developmental toxicant in animal studies, the exposure is entirely avoidable, and the guidance documents exclude pregnancy Phillips 2022 Satora 2023.

Do not use on broken, ulcerated or severely inflamed vaginal mucosa. The safety margin depends on limited absorption across an intact barrier, and that condition is exactly what is absent in severe vulvovaginitis.

Local burning, watery discharge and irritation are the common adverse effects. Persistent or severe burning is a reason to stop and be reassessed rather than to continue.

It is not a treatment for bacterial vaginosis, trichomoniasis or any sexually transmitted infection, and it is not a hygiene product. Using it on symptoms that were never cultured is how a real diagnosis gets missed Neal 2022.

This is a page about a treatment that belongs to a clinician. It is here because the site has a candida protocol and had nothing written about the one intervention that appears in the guidelines, not because anybody should start it on their own reading.

Boric Acid safety basics6 points of its own

Its own safety story

  • Never swallow it. Oral boric acid is toxic and ingestion has caused death; the capsules look like any other capsule and must be stored where a child cannot reach them.
  • Contraindicated in pregnancy. Boron is a developmental toxicant in animal studies and the exposure is avoidable.
  • Do not use on broken or ulcerated vaginal mucosa — systemic absorption rises when the barrier is gone.
  • Vaginal burning, watery discharge and irritation are the common local effects. Persistent burning means stop.
  • It is not a treatment for bacterial vaginosis, trichomoniasis or a sexually transmitted infection, and using it for symptoms that were never cultured is how a real diagnosis gets missed.
  • Not for use with a partner's exposure in mind, and not as a douche — the products sold as rinses are a different thing from the studied suppository.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run4 tests in one order, code CAMERON

The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.

  • What to watchThe culture result first, and then symptom resolution against it. This is the rare entry on this site where the read-out precedes the product: a vaginal swab that names the species is what turns a 14-day course into a treatment rather than a guess, because the whole argument for boric acid is activity against non-albicans Candida that azoles handle badly.
  • How long before it means anythingThe full 14 days, then a repeat swab. Partial improvement at day four is common and stopping there is the standard route from a treatable infection to a recurrent one.
  • What will fool youThe menstrual cycle, which moves vaginal pH and glycogen and therefore moves symptoms on its own timetable. And the diagnosis: bacterial vaginosis remits and relapses spontaneously, it is the condition most often mistaken for this one, and boric acid started on symptoms alone will appear to work on it once and fail the next three times.

The labs mapped to Boric Acid

4 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order these 4 tests

Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.

The Basics — Start Here panel, explained

Boric Acid FAQ5 common questions

What is Boric Acid?
An intravaginal antiseptic with a genuine place in the treatment of recurrent vulvovaginal candidiasis, particularly infections caused by non-albicans species such as Candida glabrata that are intrinsically less susceptible to azole drugs. It appears in guideline and expert-consensus documents as a second-line option, at a defined dose, for a defined duration — and it is a poison if it is swallowed.
What is the suggested dose of Boric Acid?
The dose in the literature is 600 mg intravaginally once daily for 14 days. It is not a maintenance product and it is not a daily hygiene product. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Boric Acid for?
Women with culture-confirmed recurrent or non-albicans vulvovaginal candidiasis, working with a clinician. Nobody else.
Which labs show whether Boric Acid is doing anything?
TSH (Thyroid-Stimulating Hormone), Free T4 (Thyroxine), Total Testosterone, Vitamin D (25-Hydroxy). Draw a baseline before you start, then recheck.
Where can I buy Boric Acid?
Coach Cam sources Boric Acid from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Boric Acid is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Boric Acid is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Boric Acid is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Boric Acid in your full stack: what it runs with, and what it cancels out
  • How it fits with your peptides: what it pairs with, and what it overlaps
  • The retest plan: TSH (Thyroid-Stimulating Hormone) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool